leucine and Brain Inflammation

leucine has been researched along with Brain Inflammation in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (5.13)24.3611
2020's37 (94.87)2.80

Authors

AuthorsStudies
Buganza, M; Cantalupo, G; Filipponi, S; Giometto, B; Pellegrini, M; Piffer, S; Poretto, V; Tanel, R1
Fan, C; Gao, L; Huang, X; Li, L; Shen, H; Ye, J1
Butzkueven, H; Monif, M; O'Brien, TJ; Seery, N1
Baudin, P; Charpier, S; Cousyn, L; Lecas, S; Lehongre, K; Mahon, S; Navarro, V; Roussel, D; Whitmarsh, S1
Li, G; Liu, X; Ren, J; Wang, M; Wang, Q; Yu, T1
Fujita, H; Shioda, M; Suzuki, K1
Cui, CS; Feng, F; Li, HY; Liu, XW; Qiao, S; Yang, XD1
Cai, HB; Kang, HC; Kirsch, HE; Li, C; Luo, HY; Tang, ZP; Xi, XC; Zhao, X; Zhou, Q1
Guan, H; Hou, L; Li, H; Ren, H; Wan, L; Wang, P; Wang, Z1
Aboseif, A; Galioto, R; Krishnan, K; Kunchok, A; Lace, J1
Banks, P; Blank, CU; Boehmerle, W; Compter, A; Endres, M; Enokida, T; French, LE; Gesierich, A; Hagenacker, T; Harvey, C; Hassel, JC; Heinzerling, LM; Huehnchen, P; Hundsberger, T; Kähler, KC; Knauss, S; Long, GV; Meier, F; Mohr, R; Müller-Jensen, L; Reinhardt, L; Salzmann, M; Schlaak, M; Schöberl, F; Seggewiss-Bernhardt, R; Soon, JA; Spain, L; Tahara, M; Ugurel, S; Versluis, JM; von Baumgarten, L; Zierold, S; Zimmer, L1
Annoni, JM; Meier, L; Petersen, JA; Weinrebe, W1
Chen, L; Chen, X; Chen, Y; Jiang, L; Li, X; Qiao, T; Wei, H; Xu, Y1
Hara, M; Kawazoe, T; Murayama, A; Nakajima, H; Sugaya, K; Takahashi, K; Tobisawa, S1
Angstwurm, K; Bergh, FT; Bien, CG; Bogarin, Y; Doppler, K; Finke, A; Geis, C; Gerner, ST; Handreka, R; Häusler, M; Hellwig, K; Kaaden, T; Kaufmann, M; Kellinghaus, C; Koertvelyessy, P; Kraft, A; Kunze, A; Lewerenz, J; Leypoldt, F; Madlener, M; Malter, M; Melzer, N; Menge, T; Mues, S; Paliantonis, A; Prüss, H; Rauer, S; Reimann, G; Ringelstein, M; Rostásy, K; Schirotzek, I; Schwabe, J; Sokolowski, P; Suesse, M; Sühs, KW; Surges, R; Tauber, SC; Thaler, F; Urbanek, C; von Podewils, F; Wandinger, KP; Wildemann, B; Zettl, U1
Anderyas, P; Halliday, A; Reardon, K1
Gao, N; Zhang, WJ1
Chen, J; Huo, T; Luo, X; Wang, T; Zhao, J1
Ching, E; Mohammed, H; Murdoch, H1
Karvigh, SA; Salehizadeh, S; Vahabizad, F1
Cui, T; Hogan, RE; Li, G; Liu, X; Lv, R; Wang, Q; Yu, T1
Jin, Y; Li, HY; Liu, XW; Qiao, S; Wang, AH; Wang, ZH; Zhang, SC1
Bittner, D; Düzel, E; Goihl, A; Korte, M; Körtvélyessy, P; Leypoldt, F; Ludewig, S; Reinhold, D; Rohne, J; Salzburger, L; Schraven, B1
Li, H; Li, J; Li, L; Wang, S; Wang, Y; Zhao, X1
Chae, JH; Jang, S; Kim, KJ; Kim, SY; Kim, WJ; Lim, BC1
Chen, X; Deng, B; Ge, J; Jin, L; Liu, X; Tang, W; Wang, J; Xue, L; Yu, H; Zhang, X; Zuo, C1
Chen, L; Liu, Y; Su, T1
Qu, G; Wang, S; Wang, Y; Yu, X; Zhao, J1
Barwick, T; Dixon, L; Jesuthasan, A; Johnson, MR; Molloy, S; Tomlinson, JAP1
Abbatemarco, JR; Aboseif, A; Amin, M; Cohen, JA; Galioto, R; Kunchok, A; Lapin, B; Li, Y; Milinovich, A; Punia, V; Rae-Grant, AD1
Çarçak, N; Korkmaz, HY; Küçükali, CI; Onat, F; Pişkin, ŞA; Şanlı, E; Tüzün, E; Ulusoy, CA1
Liu, W; Liu, Y; Liu, Z; Ryuji, S; Shao, M1
Guo, D; Liang, J; Liu, L; Ma, H; Man, X; Sun, J; Tao, S; Yuan, X; Zhang, J1
Li, JH; Li, JM; Lu, H; Ma, XR; Peng, T1
Goto, J; Iwata, NK; Kawai, M; Murai, H; Nakajima, H; Orimo, K; Takeda, K1
Binks, SNM; Easton, A; Husain, M; Irani, SR; Leite, MI; Okai, D; Veldsman, M1
Chen, J; Guan, H; Huang, Y; Jin, L; Lin, N; Liu, Q; Lu, Q1
Gao, XY; Huang, Y; Liu, HQ; Shi, YY; Wang, CC; Wu, YY; Yang, HL; Zhang, JW; Zhang, YX1
Day, GS1

Reviews

3 review(s) available for leucine and Brain Inflammation

ArticleYear
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.
    Autoimmunity reviews, 2022, Volume: 21, Issue:5

    Topics: Autoantibodies; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine

2022
Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature.
    Journal of medical case reports, 2022, Nov-09, Volume: 16, Issue:1

    Topics: Autoantibodies; Encephalitis; Female; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Iran; Leucine; Limbic Encephalitis; Neoplasm Recurrence, Local; Seizures

2022
Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
    BMC neurology, 2023, Jun-30, Volume: 23, Issue:1

    Topics: Autoimmune Diseases of the Nervous System; Child; Encephalitis; Female; Glioma; Humans; Hyponatremia; Leucine; Pain

2023

Other Studies

36 other study(ies) available for leucine and Brain Inflammation

ArticleYear
Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
    European journal of neurology, 2022, Volume: 29, Issue:3

    Topics: Autoantibodies; Encephalitis; Glioma; Hashimoto Disease; Humans; Leucine; Limbic Encephalitis; Male; Middle Aged

2022
Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    The Journal of neuropsychiatry and clinical neurosciences, 2022,Spring, Volume: 34, Issue:2

    Topics: Adrenal Cortex Hormones; Autoantibodies; Encephalitis; Female; Glioma; Humans; Hyponatremia; Immunologic Factors; Immunotherapy; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Seizures

2022
Kv1.1 channels inhibition in the rat motor cortex recapitulates seizures associated with anti-LGI1 encephalitis.
    Progress in neurobiology, 2022, Volume: 213

    Topics: Animals; Encephalitis; Glioma; Hashimoto Disease; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Motor Cortex; Rats; Seizures

2022
Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.
    Acta neurologica Scandinavica, 2022, Volume: 146, Issue:2

    Topics: Autoantibodies; Bayes Theorem; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Retrospective Studies

2022
Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
    BMC neurology, 2022, Apr-21, Volume: 22, Issue:1

    Topics: Aged; Autoantibodies; Contrast Media; Encephalitis; Gadolinium; Glioma; Humans; Hyponatremia; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Methylprednisolone; Sodium

2022
Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2022, Volume: 101

    Topics: Autoantibodies; China; Contactin 2; Encephalitis; Female; Glioma; Hashimoto Disease; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Male; Potassium Channels, Voltage-Gated; Retrospective Studies

2022
What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
    European neurology, 2022, Volume: 85, Issue:6

    Topics: Autoantibodies; Dementia; Encephalitis; Female; Glioma; Humans; Hyponatremia; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Neuroimaging; Status Epilepticus

2022
Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
    BMC neurology, 2022, Jul-27, Volume: 22, Issue:1

    Topics: Autoantibodies; Encephalitis; Glioma; Hiccup; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Seizures

2022
Cognitive outcomes in anti-LGI-1 encephalitis.
    Journal of the International Neuropsychological Society : JINS, 2023, Volume: 29, Issue:6

    Topics: Adult; Aged; Cognition; Cognitive Dysfunction; Encephalitis; Epilepsy, Temporal Lobe; Female; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Male; Neuropsychological Tests; Retrospective Studies

2023
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 175

    Topics: Autoantibodies; Cohort Studies; Encephalitis; Glioma; Herpesvirus 1, Human; Humans; Immune Checkpoint Inhibitors; Intracellular Signaling Peptides and Proteins; Leucine; Retrospective Studies

2022
Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis.
    Clinical interventions in aging, 2022, Volume: 17

    Topics: Aged; Anticonvulsants; Confusion; Dementia; Encephalitis; Female; Hallucinations; Hashimoto Disease; Humans; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Potassium Channels, Voltage-Gated; Rituximab; Seizures

2022
Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Anticonvulsants; Dyskinesias; Encephalitis; Glioma; Humans; Hyperhidrosis; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Steroids

2022
Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
    Internal medicine (Tokyo, Japan), 2023, Jun-01, Volume: 62, Issue:11

    Topics: Autoantibodies; Contactins; Encephalitis; Humans; Intracellular Signaling Peptides and Proteins; Isaacs Syndrome; Leucine; Limbic Encephalitis

2023
Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
    Neurology(R) neuroimmunology & neuroinflammation, 2022, Volume: 9, Issue:6

    Topics: Autoantibodies; Encephalitis; Glutamate Decarboxylase; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Prospective Studies; Receptors, N-Methyl-D-Aspartate; Seizures; Status Epilepticus

2022
Anti-LGI1-Associated Myopathy in the Setting of Neuromuscular Hyperexcitability Syndrome.
    JAMA neurology, 2022, 12-01, Volume: 79, Issue:12

    Topics: Autoantibodies; Encephalitis; Humans; Leucine; Limbic Encephalitis; Muscular Diseases

2022
Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:20

    Topics: Adrenal Cortex Hormones; Autoantibodies; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Nephrosis, Lipoid

2022
A Chinese female patient with LGI1 and mGluR5 antibodies: A case report.
    Medicine, 2022, Oct-28, Volume: 101, Issue:43

    Topics: Aged; Autoantibodies; China; Encephalitis; Female; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Ischemic Stroke; Leucine; Limbic Encephalitis; Seizures

2022
Leucine-rich glioma-inactivated 1 antibody encephalitis as a rare cause of delirium.
    Geriatrics & gerontology international, 2022, Volume: 22, Issue:12

    Topics: Delirium; Encephalitis; Glioma; Humans; Leucine

2022
Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis.
    Journal of neuroimmunology, 2022, 12-15, Volume: 373

    Topics: Encephalitis; Glioma; Humans; Hyponatremia; Leucine; Prognosis

2022
Cytokines/chemokines and immune checkpoint molecules in anti-leucine-rich glioma-inactivated 1 encephalitis.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, Volume: 44, Issue:3

    Topics: Autoantibodies; Chemokines; Cytokines; Encephalitis; Glioma; Humans; Immune Checkpoint Proteins; Intracellular Signaling Peptides and Proteins; Leucine

2023
Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
    Cells, 2023, 01-11, Volume: 12, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoantibodies; Encephalitis; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Mice; N-Methylaspartate; Phenotype; Seizures

2023
CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Autoantibodies; Biomarkers; Chitinase-3-Like Protein 1; Chitinases; Encephalitis; Glioma; Humans; Leucine; Limbic Encephalitis

2022
A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Brain & development, 2023, Volume: 45, Issue:6

    Topics: Adult; Autoantibodies; Child; Dyskinesias; Encephalitis; Female; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Methylprednisolone; Seizures

2023
Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis.
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:8

    Topics: Autoimmune Diseases of the Nervous System; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Neuroinflammatory Diseases; Positron-Emission Tomography; Receptors, GABA; Seizures

2023
Leucine-rich glioma-inactivated protein 1 antibody-associated encephalitis in a 22-month-old girl: a case report.
    BMC pediatrics, 2023, 08-08, Volume: 23, Issue:1

    Topics: Autoantibodies; Autoimmune Diseases of the Nervous System; Encephalitis; Female; Glioma; Humans; Immunosuppressive Agents; Infant; Intracellular Signaling Peptides and Proteins; Leucine

2023
LGI1 Encephalitis and IgG4-Related Disease: Rare Conditions Collide.
    Neurology(R) neuroimmunology & neuroinflammation, 2023, Volume: 10, Issue:6

    Topics: Autoantibodies; Encephalitis; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Intracellular Signaling Peptides and Proteins; Leucine

2023
Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis.
    Neurology(R) neuroimmunology & neuroinflammation, 2024, Volume: 11, Issue:1

    Topics: Aged; Autoimmune Diseases of the Nervous System; Encephalitis; Female; Humans; Immunoglobulin G; Leucine; Male

2024
Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Animals; Autoantibodies; Autoimmune Diseases of the Nervous System; Cognition; Encephalitis; Epilepsy; Glioma; Humans; Immunoglobulin G; Leucine; Rats; Rats, Wistar; Seizures

2023
Anti-leucine-rich glioma-inactivated 1-positive limbic encephalitis presenting hypothalamic symptoms.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020, Volume: 41, Issue:6

    Topics: Autoantibodies; Encephalitis; Glioma; Humans; Leucine; Limbic Encephalitis; Proteins

2020
Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
    Internal medicine (Tokyo, Japan), 2020, Volume: 59, Issue:2

    Topics: Adrenal Cortex Hormones; Autoantibodies; Encephalitis; Glioma; Hashimoto Disease; Humans; Hyponatremia; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Middle Aged; Seizures; Thrombocythemia, Essential

2020
[Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis].
    Zhonghua yi xue za zhi, 2020, Jul-07, Volume: 100, Issue:25

    Topics: Autoantibodies; Encephalitis; Glioma; Humans; Leucine; Neoplasm Recurrence, Local; Retrospective Studies

2020
Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
    Internal medicine (Tokyo, Japan), 2021, Sep-15, Volume: 60, Issue:18

    Topics: Aged; Autoantibodies; Encephalitis; Glioma; Humans; Hypotension, Orthostatic; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Male; Potassium Channels, Voltage-Gated

2021
Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
    JAMA neurology, 2021, 05-01, Volume: 78, Issue:5

    Topics: Antibodies; Autoantibodies; Cognition; Cognitive Dysfunction; Encephalitis; Fatigue; Glioma; Humans; Leucine

2021
Long-term seizure outcomes in patients with anti-Leucine-rich glioma-inactivated 1 encephalitis.
    Epilepsy & behavior : E&B, 2021, Volume: 122

    Topics: Aged; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Seizures

2021
[Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhonghua yi xue za zhi, 2017, May-09, Volume: 97, Issue:17

    Topics: Antibodies; Autoantibodies; Encephalitis; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Proteins; Seizures

2017
Rethinking Outcomes in Leucine-Rich, Glioma-Inactivated 1 Protein Encephalitis: "Good" Isn't Good Enough.
    JAMA neurology, 2017, 01-01, Volume: 74, Issue:1

    Topics: Cognition; Encephalitis; Glioma; Hippocampus; Humans; Leucine

2017